Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Feb 19, 2025
Date Accepted: Jun 17, 2025

The final, peer-reviewed published version of this preprint can be found here:

Evaluating the Effect of a Molecular Point-of-Care Test on Acute Respiratory Infections in General Practice: Protocol for a Cluster Randomized Trial

Balasubramaniam K, Simonsen LM, Kongstad LP, Thilsing T, Wehberg S, Hallas J, Sopina L, Nielsen JB, Overbeck G, Hvidt EA, Jarbøl DE, Rasmussen TL, Søndergaard J

Evaluating the Effect of a Molecular Point-of-Care Test on Acute Respiratory Infections in General Practice: Protocol for a Cluster Randomized Trial

JMIR Res Protoc 2025;14:e72842

DOI: 10.2196/72842

PMID: 40921063

PMCID: 12455145

A cluster-randomized trial evaluating the effect of molecular point-of-care test for acute respiratory infections in general practice: a study protocol

  • Kirubakaran Balasubramaniam; 
  • Line Maria Simonsen; 
  • Line Planck Kongstad; 
  • Trine Thilsing; 
  • Sonja Wehberg; 
  • Jesper Hallas; 
  • Liza Sopina; 
  • Jesper Bo Nielsen; 
  • Gritt Overbeck; 
  • Elisabeth Assing Hvidt; 
  • Dorte Ejg Jarbøl; 
  • Tina Lein Rasmussen; 
  • Jens Søndergaard

ABSTRACT

Background:

Acute respiratory infections (ARIs) are frequent reasons for medical consultations in general practice. Point-of-care (POC) diagnostic equipment may support an attractive and efficient handling of these contacts including provision of a more precise and exact microbial diagnosis. However, several contextual factors may impact such implementation.

Objective:

To evaluate the effect of POC PCR test availability in general practice on subsequent 1) number of re-contacts for patients with symptoms of ARIs (primary outcome), and 2) hospital admissions, 3) deaths, 4) antibiotic prescriptions, 5) as well as health-related quality-of-life (HQoL), 6) general practitioner (GP) and patient satisfaction, 7) costs, and 8) cost-effectiveness as secondary outcomes. Furthermore, we aimed to identify and analyze contextual factors that influenced the implementation process.

Methods:

This study is a cluster-randomized crossover, non-blinded superiority trial with a 1:1 allocation ratio between usual care (control) and POC PCR test availability (intervention). The unit of randomization was GP clinic. The trial consisted of two periods of seven weeks (intervention and control) during the peak season of ARI in Denmark. During both periods, all patients with ARI symptoms were registered consecutively. During the intervention period, the GPs had free access to a POC PCR device with an option to test ARI patients for group A streptococcus, severe acute respiratory syndrome coronavirus 2, influenza, and respiratory syncytial virus. Questionnaire data was collected at day 0, day 7, 14, and day 28 after the initial contact (HQoL, absenteeism and presentism among patients, patient satisfaction) and after finalization of the study period (GP satisfaction). Data on re-contacts, hospital admissions, redeemed antibiotic prescriptions, costs and deaths will be retrieved from the Danish national registries. The implementation process will be evaluated based on data from interviews with users of POC PCR tests (GPs, staff, and patients) and from observations in the GP clinics.

Results:

None

Conclusions:

POC PCR technology is not yet available to Danish general practice. In this study, the effects of introducing POC PCR for diagnosing ARI is explored, measuring clinical, economical, and organizational aspects of the use of POC PCR in general practice and exploring behavioral, organizational, and communicative factors that emerge during – and which may affect – implementation processes. This study will thus provide valuable information about the diagnostic conditions and possibilities in general practice as well as the organization of primary health care. Clinical Trial: The study is approved by University of Southern Denmark’s Research & Innovation Organisation (SDU RIO) (journal number: 11.907) and The Research Ethics Committee (Case no. 23/1584). Further the study is registered at ClinicalTrials.gov (ID number: NCT06120153)


 Citation

Please cite as:

Balasubramaniam K, Simonsen LM, Kongstad LP, Thilsing T, Wehberg S, Hallas J, Sopina L, Nielsen JB, Overbeck G, Hvidt EA, Jarbøl DE, Rasmussen TL, Søndergaard J

Evaluating the Effect of a Molecular Point-of-Care Test on Acute Respiratory Infections in General Practice: Protocol for a Cluster Randomized Trial

JMIR Res Protoc 2025;14:e72842

DOI: 10.2196/72842

PMID: 40921063

PMCID: 12455145

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.